USAB NY, INC. v. GLIC HEALTH, LLC

Court of Chancery of Delaware·Decided May 20, 2026·No. C.A. No, 2026-0052-CDW·Published

Opinion

IN THE COURT OF CHANCERY OF THE STATE OF DELAWARE USAB NY INC., Plaintiff,

v. C.A. No. 2026-0052-CDW GLIC HEALTH LLC, Defendant.

REPORT DENYING PLAINTIFF’S MOTION FOR JUDGMENT ON THE PLEADINGS

Date Submitted: May 7, 2026 Date Decided: May 20, 2026

Kurt M. Heyman, Elizabeth A. DeFelice, HEYMAN ENERIO GATTUSO & HIRZEL LLP, Wilmington, Delaware; Joseph L. Motto, Michael J. Stern, WINSTON & STRAWN LLP; Counsel for Plaintiff

Stephen C. Norman, POTTER ANDERSON & CORROON LLP, Wilmington, Delaware; Counsel for Defendant

WRIGHT, M.

One member of a Delaware limited liability company seeks advancement from the entity for fees and expenses it is incurring in prosecuting direct and derivative litigation it initiated against the entity’s other two members. It contends the word “defend” always creates an advancement right when used in the sequence of “indemnify, defend, and save harmless,” and unambiguously compels the entity to advance the member’s offensive litigation fees and expenses. Considering the entity’s operating agreement in light of applicable Delaware law, I conclude the term “defend” is ambiguous and I cannot grant the member’s motion for judgment on the pleadings.

I. BACKGROUND

Plaintiff USAB NY Inc. is one of two 50% members of defendant Glic Health LLC. 1 Last November, USAB sued Glic’s other 50% member and manager, Christopher Jacobs, for “breaches of contract, bad faith, willful misconduct, self-dealing, breaches of fiduciary duties, creation of false records, and abuse of his position as Managing Member and Chief Executive Officer of Glic[.]”2 USAB also asserted aiding and abetting claims against Glic’s non- voting member and Chief Operating Officer, Alexander Glovsky. 3

1 USAB is owned by Sean Conaghan. See Verified Compl. for Advancement ¶¶ 2, 6,

Dkt. 1 (“Complaint” and cited as “Compl.”). 2 Verified Compl. ¶¶ 1–3, USAB NY Inc. v. Jacobs, C.A. No. 2025-1386-JTL (Del.

Ch.) (“Underlying Action”), Compl. Ex. B. 3 Id.

USAB now seeks advancement of its fees and expenses incurred in the Underlying Action under language in Glic’s operating agreement that requires Glic to “indemnify, defend, and save harmless” USAB “from any loss, cost, damage, fee[,] . . . or expense incurred by reason of [USAB]’s status” as a member. 4 Because “indemnify” and “save harmless” work together and do not create a right to advancement,5 USAB focuses its attention on “defend.” According to USAB, the plain and unambiguous meaning of “defend” as used in the Operating Agreement requires Glic to fund USAB’s offensive litigation against Jacobs and Glovsky on an ongoing basis. 6 Stated colloquially, USAB argues “defend” unambiguously means “advance” and “advance” unambiguously includes “attack,” so “defend” unambiguously means “attack,” and I must recognize this transitive 7 construction of the Operating Agreement as the only reasonable interpretation of its terms.

4 Second Am. & Restated Ltd. Liab. Operating Agreement § 3(h)(iv), Compl. Ex. A

(“Operating Agreement”). 5 See Morgan v. Grace, 2003 WL 22461916, at *3 (Del. Ch. Oct. 29, 2003) (rejecting

argument “indemnify and save harmless” provision in LLC agreement created an advancement right); Majkowski v. American Imaging Mgmt. Servs., LLC, 913 A.2d 572, 588–90 (Del. Ch. 2006) (explaining “indemnify and hold harmless” does not create an advancement right). 6 See Opening Br. in Support of Pl.’s Mot. for J. on the Pleadings 13–17, Dkt. 14

(“Opening Br.”); Reply Br. in Support of Pl.’s Mot. for J. on the Pleadings 8–12, Dkt. 18 (“Reply Br.”); Verified Compl. for Advancement ¶¶ 24–25, 29, Dkt. 1. (“Compl.”). 7 See iBio, Inc. v. Fraunhofer USA, Inc., 2016 WL 4059257, at *11 n.108 (Del. Ch.

July 29, 2016) (“Under the transitive property of equality, if a=b and b=c, then a=c.”).

II. LEGAL STANDARD

The court grants a motion for judgment on the pleadings under Court of Chancery Rule 12(c) “only when no material issue of fact exists and the movant is entitled to judgment as a matter of law.” Desert Equities, Inc. v. Morgan Stanley Leveraged Equity Fund II, L.P., 624 A.2d 1199, 1205 (Del. 1993). Judgment on the pleadings “is a proper framework for enforcing unambiguous contracts[,]” but if “the meaning is ambiguous . . . a court cannot render judgment on the pleadings.” CURO Intermediate Hldgs. Corp. v. Sparrow Purchaser, LLC, 2024 WL 2847264, at *4 (Del. Ch. June 5, 2024) (first quoting OSI Sys., Inc. v. Instrument Corp., 892 A.2d 1086, 1090 (Del. Ch. 2006), and then quoting Fiat N. Am. LLC v. UAW Retiree Med. Benefits Tr., 2013 WL 3963684, at *7 (Del. Ch. July 30, 2013)).

Delaware’s principles of contract interpretation are, as the Supreme Court has noted, “well-established.” Weinberg v. Waystar, Inc., 294 A.3d 1039, 1043 (Del. 2023). “Delaware adheres to the ‘objective’ theory of contracts, i.e. a contract’s construction should be that which would be understood by an objective, reasonable third party.” Id. at 1044 (quoting Osborn ex rel. Osborn v. Kemp, 991 A.2d 1153, 1159 (Del. 2010)). Our courts will “enforce the plain meaning of clear and unambiguous language,” but “[l]anguage is ambiguous if it is susceptible to more than one reasonable interpretation.” Id. (quoting Manti Hldgs, LLC v. Authentix Acq. Co., Inc., 261

A.3d 1199, 1208 (Del. 2021)). Ultimately, “[t]he determination of ambiguity lies within the sole province of the court.” Id. (quoting Osborn, 991 A.2d at 1160).

III. ANALYSIS

Applying the foregoing authorities here, I cannot grant judgment on the pleadings because the language in the Operating Agreement upon which USAB bases its demand for advancement of its offensive litigation expenses is not unambiguous. It fails on both parts of USAB’s proposed transitive construction: “defend” does not unambiguously mean “advance,” nor does it unambiguously mean “attack” even if it does mean “advance.”

A. “Defend” in the Operating Agreement Does Not Unambiguously Mean “Advance”

First, “defend” as used in the Operating Agreement does not unambiguously mean “advance.” To explain why, I start with the full text of the language upon which USAB demands advancement:

To the fullest extent permitted by law, the Company will indemnify, defend, and save harmless each Member, Manager, agent, and Officer of the Company, and each of the respective agents, officers, partners, managers, members, employees, representatives, directors, and shareholders of any of the foregoing, from any loss, cost, damage, fee (including without limitation, legal and expert witness fees and costs), or expense incurred by reason of (A) such party’s status as such Member, Manager, agent, officer, partner, manager, member, employee, representative, director, or shareholder,

(B) any act performed in good faith within the scope of the authority conferred by this Agreement, (C) any good faith failure or refusal to perform any act except those required by the terms of this Agreement, or (D) any performance or omission to perform any act based upon reasonable good faith reliance on the advice of accountants or legal counsel for the Company, provided that no indemnification will be given with respect to acts or omissions that constitute fraud, willful misconduct, or breach of this Agreement.8

To win its motion for judgment on the pleadings, USAB must show the foregoing language admits of only one reasonable construction and is thus unambiguous.9 But USAB cannot, because this court has held that nearly identical language in a limited liability company agreement is ambiguous with additional language absent from the Operating Agreement.

8 Operating Agreement § 3(h)(iv) (emphasis added). The double emphasis was used

Free access — add to your briefcase to read the full text and ask questions with AI

USAB NY, INC. v. GLIC HEALTH, LLC, (Del. Ct. App. 2026).

USAB NY, INC. v. GLIC HEALTH, LLC (USAB NY, INC. v. GLIC HEALTH, LLC) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Brown v. LiveOps, Inc.
903 A.2d 324 (Court of Chancery of Delaware, 2006)
Lorillard Tobacco Co. v. American Legacy Foundation
903 A.2d 728 (Supreme Court of Delaware, 2006)
Kaung v. Cole National Corp.
884 A.2d 500 (Supreme Court of Delaware, 2005)
Majkowski v. American Imaging Management Services, LLC
913 A.2d 572 (Court of Chancery of Delaware, 2006)
OSI Systems, Inc. v. Instrumentarium Corp.
892 A.2d 1086 (Court of Chancery of Delaware, 2006)
At & T Corp. v. Clarendon American Insurance
931 A.2d 409 (Supreme Court of Delaware, 2007)
Thunderstik Lodge, Inc. v. Reuer
2000 SD 84 (South Dakota Supreme Court, 2000)
Estate of Osborn Ex Rel. Osborn v. Kemp
991 A.2d 1153 (Supreme Court of Delaware, 2010)
Rhone-Poulenc Basic Chemicals Co. v. American Motorists Insurance Co.
616 A.2d 1192 (Supreme Court of Delaware, 1992)
Eagle Industries, Inc. v. DeVilbiss Health Care, Inc.
702 A.2d 1228 (Supreme Court of Delaware, 1997)
John Solak v. Paylocity Holding Corporation
153 A.3d 729 (Court of Chancery of Delaware, 2016)
Sheehan v. Modern Continental/Healy
822 N.E.2d 305 (Massachusetts Appeals Court, 2005)
Clyde v. Franciscan Sisters of Allegany, N.Y., Inc.
190 N.Y.S.3d 714 (Appellate Division of the Supreme Court of New York, 2023)